<!–
–>
Analysis of the key themes driving M&A activity reveals that artificial intelligence accounted for 7 medical devices deals announced in Q3 2022, worth a total value of $3.7m, according to GlobalData’s Deals Database. The $2.9m acquisition of Pilloxa by iZafe Group was the industry’s largest disclosed deal.
In value terms, artificial intelligence-related deal activity decreased by 82% in Q3 2022 compared with the previous quarter’s total of $20m and fell by 98% as compared to Q3 2021. Related deal volume increased by 133% in Q3 2022 versus the previous quarter and was 22% lower than in Q3 2021.
- Coinsmart. Europe’s Best Bitcoin and Crypto Exchange.Click Here
- Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
- Source: https://www.medicaldevice-network.com/feed/
